Skip to content
buyWeak cluster of 2

Haeberlein Samantha L. Budd bought $21k of VIGL

director at Vigil Neuroscience, Inc.. 12,000 shares at an average of $1.71, traded Dec 19, 2024, filed Dec 19, 2024.

Conviction score
31
Value
$21k
12,000 shares
Holdings after
12,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $21k at market
    0
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    No price history yet
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000950170-24-138619, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 19, 2024POpen-market purchase
Common Stock
+12,000$1.71$21k12,000Dec 19, 2024

Related signals

Other insiders at Vigil Neuroscience, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
38Weak
VIGLbuy 2
Vigil Neuroscience, Inc.
Ivana Magovcevic-Liebisch
President and CEO
$8,400
5,000 shares
+2%
38Weak
VIGLbuy 2
Vigil Neuroscience, Inc.
Ivana Magovcevic-Liebisch
President and CEO
$8,350
5,000 shares
+2%
33Weak
VIGLbuy 2
Vigil Neuroscience, Inc.
Ivana Magovcevic-Liebisch
President and CEO
$12k
5,000 shares
+2%
25Weak
VIGLbuy
Vigil Neuroscience, Inc.
Ivana Magovcevic-Liebisch
President and CEO
$15k
4,000 shares
+2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Haeberlein Samantha L. Budd bought $21k of VIGL | InsiderTell